Where investment dollars are flowing in biotech startups

Biotech startups that utilize platform-based therapeutics received a large proportion of investment dollars from 2019 to 2021, according to a June 10 McKinsey article

Globally, venture capital firms invested over $52 billion into biotech startups, counting investments from seed to series C. The largest proportion of funding went to platform-based therapeutics, bringing in $34.6 billion in total, while other therapeutics accounted for $17.2 billion in funding.

Here are five platform-based startup types to watch, as they received the most VC investment:

  1. Cell therapy represented $7.7 billion of total funding. 

  2. Next-generation gene therapies brought in $7.6 billion in funding. 

  3. Precision medicine companies got $4.5 billion in funding.

  4. Machine-learning-enabled drug discovery brought in $4.4 billion.

  5. Startups focusing on hard-to-hit targets, or "undruggable" targets, got $4 billion in funding.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars